HRS-1893 Tablet

DRUG3 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

Heart Failure With Preserved Ejection FractionHypertrophic CardiomyopathyObstructive Hypertrophic Cardiomyopathy

Phase 1

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

CompletedNCT06354556

Shandong Suncadia Medicine Co., Ltd.Obstructive Hypertrophic Cardiomyopathy

Start: 2024-04-26End: 2024-05-20Updated: 2024-06-06

Phase 2

A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy

RecruitingNCT07021963

Shandong Suncadia Medicine Co., Ltd.Hypertrophic Cardiomyopathy

Start: 2025-07-04End: 2027-12-31Target: 300Updated: 2025-09-10

A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction

RecruitingNCT07269717

Shandong Suncadia Medicine Co., Ltd.Heart Failure With Preserved Ejection Fraction

Start: 2026-03-30End: 2027-05-01Target: 48Updated: 2026-05-11